Eli Lilly and Co. (LLY) Earns Outperform Rating from Credit Suisse Group AG

Eli Lilly and Co. (LLY) Earns Outperform Rating from Credit Suisse Group AG


's stock had its "outperform" rating restated by stock analysts at Credit Suisse Group AG in a report released on Wednesday. They presently have a $87.00 target price on the stock.



from Biotech News